Sign in
4

Changes in Ownership

Harmony Biosciences Holdings, Inc. Filed Acc 0001415889-25-001549

CHIEF COMMERCIAL OFFICER sold 10,507 shares at $37.01 ($388,841)

  • CHIEF COMMERCIAL OFFICER acquired 10,507 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dierks Jeffrey CHIEF COMMERCIAL OFFICER 2025-01-15 Option exercise 10b5-1 +10,507 $33.44 $351,354 10,507 D: show line 1 in the form
Dierks Jeffrey CHIEF COMMERCIAL OFFICER 2025-01-15 Sale 10b5-1 −10,507 $37.01 $388,841 0 D: show line 2 in the form
Open-market sales · 10,507 sh · avg $37.01 · $388,841

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dierks Jeffrey CHIEF COMMERCIAL OFFICER 2025-01-15 Option exercise · Stock Option 10b5-1 −10,507 36,213 D: show line 3 in the form
Loading xslF345X05/form4-01162025_040101.xml…